Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-03-16 GRIFFIN MICHELLE RENEE Director Option exercise · Stock Option (Right to Buy) −1,500 83,000
2021-03-15 GRIFFIN MICHELLE RENEE Director Option exercise +4,500 $7.80 $35K 6,004
2021-03-15 GRIFFIN MICHELLE RENEE Director Sale −891 $41.17 $37K 5,113
2021-03-15 GRIFFIN MICHELLE RENEE Director Sale −3,609 $41.89 $151K 1,504
2021-03-15 GRIFFIN MICHELLE RENEE Director Option exercise · Stock Option (Right to Buy) −4,500 84,500
2021-03-15 LO FRANCIS Chief People Officer Option exercise +2,000 $7.80 $16K 22,604
2021-03-15 LO FRANCIS Chief People Officer Sale −878 $41.57 $36K 21,726
2021-03-15 LO FRANCIS Chief People Officer Sale −1,122 $42.03 $47K 20,604
2021-03-15 LO FRANCIS Chief People Officer Option exercise · Stock Option (Right To Buy) −2,000 155,000
2021-03-15 BENZENO SHARON Chief Business Development Off Option exercise +1,354 $31.71 $43K 24,248
2021-03-15 BENZENO SHARON Chief Business Development Off Sale −340 $41.22 $14K 23,908
2021-03-15 BENZENO SHARON Chief Business Development Off Sale −1,014 $41.85 $42K 22,894
2021-03-15 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −1,354 47,396
2021-03-10 Cohen Chad M Chief Financial Officer Option exercise +10,000 $6.32 $63K 31,604
2021-03-10 Cohen Chad M Chief Financial Officer Sale −10,000 $42.54 $425K 21,604
2021-03-10 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right to Buy) −10,000 45,000
2021-03-10 GOEL DAVID E. Director Sale −25,732 $41.47 $1.1M 12,339,358
2021-03-10 GOEL DAVID E. Director Sale −30,268 $42.38 $1.3M 12,309,090
2021-03-09 Cohen Chad M Chief Financial Officer Option exercise +10,000 $6.32 $63K 31,064
2021-03-09 Cohen Chad M Chief Financial Officer Sale −7,110 $40.02 $285K 23,954

Page 53 of 120 · 2,386 trades